التفاصيل البيبلوغرافية
| العنوان: |
Altered intestinal permeability in patients with relapsing–remitting multiple sclerosis: A pilot study. |
| المؤلفون: |
Buscarinu, Maria Chiara, Cerasoli, Benedetta, Annibali, Viviana, Policano, Claudia, Mechelli, Rosella, Romano, Silvia, Fornasiero, Arianna, Mattei, Gianluca, Umeton, Renato, Salvetti, Marco, Ristori, Giovanni, Lionetto, Luana, Capi, Matilde, Simmaco, Maurizio, Piras, Eleonora, Angelini, Daniela Francesca, Battistini, Luca |
| المصدر: |
Multiple Sclerosis Journal; Mar2017, Vol. 23 Issue 3, p442-446, 5p, 2 Charts, 2 Graphs |
| مصطلحات موضوعية: |
MULTIPLE sclerosis diagnosis, INTESTINAL diseases, DISEASE relapse, PATHOGENIC microorganisms, MULTIPLE sclerosis treatment, T cells |
| مستخلص: |
Background: Alterations of intestinal permeability (IP) may contribute to the pathophysiology of immune-mediated diseases. Objective: We investigated the possible association between IP changes and multiple sclerosis (MS). Methods: We studied 22 patients with relapsing–remitting multiple sclerosis (RRMS) and 18 age- and sex-matched healthy donors (HDs), including five twin pairs (one concordant, and four discordant for disease). Measurement of lactulose (L) and mannitol (M; two non-metabolized sugars) levels in urine samples, after an oral load, allowed to quantify gut dysfunction. Results: The proportion of participants with increased IP was significantly higher in patients than in HDs (16/22 (73%) versus 5/18 (28%); p = 0.001). Accordingly, the L/M urinary ratio showed significantly higher values in patients than in controls (p = 0.0284). Urinary mannitol concentration was significantly lower in patients than in controls (p = 0.022), suggesting a deficit of absorption from intestinal lumen. Such changes did not appear related to patients’ clinical–radiological features. Conclusion: The relatively high proportion of IP changes in RR-MS patients seems to confirm our work hypothesis and warrants more work to confirm the result on a larger sample, and to understand the implications for related immunological disturbances and intestinal microbiota alterations. Our finding may also have relevance for oral treatments, recently introduced in clinical practice. [ABSTRACT FROM AUTHOR] |
|
Copyright of Multiple Sclerosis Journal is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
